FDA Inspection
Qilu Pharmaceutical Co., Ltd. (Dongjia Site)Qilu Pharmaceutical Co., Ltd. (Dongjia Site) – FDA Inspection, May 24, 2024
Record Details
This FDA Inspection record concerns Qilu Pharmaceutical Co., Ltd. (Dongjia Site), with an inspection on May 24, 2024, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- May 24, 2024
- Product Type
- Human Drugs
View Company Profile
ID · 169ebdb8-7b4f-446a-ac03-399b804ba098
Inspection Facts
- Inspection number
- 1239802
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Qilu Pharmaceutical Co., Ltd. (Dongjia Site)
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 16, 2023 | Not classified | Office of Inspections and Investigations |
Other documents for Qilu Pharmaceutical Co., Ltd. (Dongjia Site)
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.